13F

Stock

Citius Oncology, Inc.

CTOR · held by 18 managers

Reported value

$6.86M

Holders

18

+0 new · −1 exited

Holders’ est. mark

−$34.4K

Price effect on 2 books still in the name

Largest holder

$5.58M

ARMISTICE CAPITAL, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ARMISTICE CAPITAL, LLC5.58M$5.58MHeld
Vanguard597K$597KHeld
GEODE CAPITAL MANAGEMENT, LLC220K$220KHeld
OMERS ADMINISTRATION Corp104.5K$104.5KHeld
IFP Advisors, Inc87.4K$87.4K−$34.2KAdded$20K
XTX Topco Ltd74K$74KHeld
NORTHERN TRUST CORP45.7K$45.7KHeld
State Street42.9K$42.9KHeld
TWO SIGMA INVESTMENTS, LP23.5K$23.5KHeld
BlackRock, Inc.22.3K$22.3KHeld
UBS Group AG21.5K$21.5KHeld
TWO SIGMA SECURITIES, LLC13.4K$13.4KHeld
Arkadios Wealth Advisors11.7K$11.7KHeld
OSAIC HOLDINGS, INC.11.4K$11.4KHeld
Versant Capital Management, Inc1.5K$1.5KHeld
BANK OF AMERICA CORP /DE/214$214−$220Cut−$322
Farther Finance Advisors, LLC3$3Held
ROYAL BANK OF CANADA23$0Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.